Indian journal of medical microbiology · 2026
Tracking antimicrobial resistance in typhoidal Salmonella, 2020-2024: Output from an antimicrobial resistance surveillance network in New Delhi, India.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sonal Saxena, Prabhav Aggarwal, Arpita Saxena, Amala Andrews A, Amritha Anugula, Anuj Sharma, DeNSAR members
Аннотация
BACKGROUND: Enteric fever remains a major health problem in India. Continuous monitoring of antimicrobial resistance (AMR) is essential to guide therapy and control emerging threats.
METHODS: This study aims at analysing the data of Salmonella isolates reported in Delhi NCR over past five years (2020-24). The study has data from 24 laboratories participating in the antimicrobial resistance surveillance network of Delhi. The identification of pathogen and antimicrobial susceptibility testing was performed in each lab using standard methods and the data was compiled and collated using WHONET software and shared to the network on a monthly basis.
RESULTS: A total of 10,689 isolates were analysed: 8371 (78.3%) S. Typhi; 2295 (21.5%) S. Paratyphi A; and 23 (0.2%) S. Paratyphi B. Annual isolates rose from 522 (during 2020) to 3679 (during 2024). Children aged 1-12 years accounted for 46% of cases. Over 5 years period, among S. Typhi, resistance declined for ampicillin (9.6% to 4.1%) and trimethoprim-sulfamethoxazole (8.7% to 3.5%).Chloramphenicol resistance remained ≤5.3%, however, ciprofloxacin non-susceptibility persisted (≈48-60%). Ceftriaxone resistance was rare (3 isolates). Multidrug resistance fell to 1% by 2024. S. Paratyphi A showed similar but generally lower resistance to first-line drugs, yet higher fluoroquinolone resistance (88-98%). No isolate was confirmed by nodal centre as being resistant to azithromycin or carbapenems.
CONCLUSION: Susceptibility to traditional first-line agents is improving, and multidrug resistance is low; however, fluoroquinolone resistance remains high. Ongoing AMR surveillance and prudent antibiotic use are essential to sustain treatment efficacy.
METHODS: This study aims at analysing the data of Salmonella isolates reported in Delhi NCR over past five years (2020-24). The study has data from 24 laboratories participating in the antimicrobial resistance surveillance network of Delhi. The identification of pathogen and antimicrobial susceptibility testing was performed in each lab using standard methods and the data was compiled and collated using WHONET software and shared to the network on a monthly basis.
RESULTS: A total of 10,689 isolates were analysed: 8371 (78.3%) S. Typhi; 2295 (21.5%) S. Paratyphi A; and 23 (0.2%) S. Paratyphi B. Annual isolates rose from 522 (during 2020) to 3679 (during 2024). Children aged 1-12 years accounted for 46% of cases. Over 5 years period, among S. Typhi, resistance declined for ampicillin (9.6% to 4.1%) and trimethoprim-sulfamethoxazole (8.7% to 3.5%).Chloramphenicol resistance remained ≤5.3%, however, ciprofloxacin non-susceptibility persisted (≈48-60%). Ceftriaxone resistance was rare (3 isolates). Multidrug resistance fell to 1% by 2024. S. Paratyphi A showed similar but generally lower resistance to first-line drugs, yet higher fluoroquinolone resistance (88-98%). No isolate was confirmed by nodal centre as being resistant to azithromycin or carbapenems.
CONCLUSION: Susceptibility to traditional first-line agents is improving, and multidrug resistance is low; however, fluoroquinolone resistance remains high. Ongoing AMR surveillance and prudent antibiotic use are essential to sustain treatment efficacy.